Home

Drug firms will have to reveal full cost of new treatments to NICE

1999-02-11T00:00:00

Drug companies will be expected to produce evidence of 'the total cost to the NHS' of adopting new treatments under a proposed appraisal process for the National Institute for Clinical Excellence.

You need to be signed in to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Subscribe

to HSJ

Sign into your account here